[Skip to Content]
Radiation Oncology

Standard vs Dose-Escalated Radiotherapy in Medium-Risk Prostate Cancer

JAMA Oncology
Published Online: March 15, 2018 Audio Author Interview 9 min 43 sec
<title>Standard vs Dose-Escalated Radiotherapy in Medium-Risk Prostate Cancer</title>
Backward 15 Play Pause Forward 15
1x
0:00 / 0:00
Download MP3

Interview with Jeff Michalski, MD, author of Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer: The NRG Oncology RTOG 0126 Randomized Clinical Trial

Subscribe

Subscribe on your favorite podcast source to receive future episodes of this podcast.
Learn more about this JAMA Network podcast here

Related Articles

  1. Standard vs Dose-Escalated Radiotherapy in Medium-Risk Prostate Cancer

JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 Credit(s)™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC

See More About

Oncology Prostate Cancer Radiation Oncology Urology Urologic Cancer
Close
Close

Name Your Search

Save Search
Close
Close

Lookup An Activity

or

My Saved Searches

You currently have no searches saved.

Close

My Saved Courses

You currently have no courses saved.

Close
Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue